missing translation for 'onlineSavingsMsg'
Learn More
Learn More
EphB1/EphB2 Polyclonal Antibody, Invitrogen™
Descrizione
The Eph subfamily represents the largest group of receptor protein tyrosine kinases identified to date. While the biological activities of these receptors have yet to be determined, there is increasing evidence that they are involved in central nervous system function and in development. The Eph subfamily receptors of human origin (and their murine/avian homologs) include EphA1(Eph), EphA2 (Eck), EphA3 (Hek4), EphA4 (Hek8), EphA5 (Hek7), EphA6 (Hek12),EphA7 (Hek11/MDK1), EphA8 (Hek3), EphB1 (Hek6), EphB2 (Hek5), EphB3(Cek10, Hek2), EphB4 (Htk), EphB5 (Hek9) and EphB6 (Mep). Ligands for Eph receptors include ephrin-A4 (LERK-4) which binds EphA3 and EphB1. In addition, Ephrin-A2 (Elf-1) has been described as the ligand for EphA4, ephrin-A3 (Ehk1-L) as the ligand for EphA5 and ephrin-B2 (Htk-L) as the ligand for EphB4 (Htk).
Specifica
Specifica
| Antigene | EphB1/EphB2 |
| Applicazioni | Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot |
| Classificazione | Polyclonal |
| Concentrazione | 1 mg/mL |
| Coniugato | Unconjugated |
| Formulazione | Dulbecco′s PBS with 150mM NaCl, 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | EPHB1 |
| N. accesso geni | P29323, P54762, P54763, Q8CBF3, P09759 |
| Alias gene | ETK2; HEK2; TYRO6; EPHB3, DRT; ERK; CAPB; Hek5; PCBC; EPHT3; Tyro5; MGC87492; EPHB2, Ephrin type-B receptor 1; Tyrosine-protein kinase receptor EPH-2; NET, HEK-6, ELK, Ephrin type-B receptor 2, Ephrin B1, EphrinB1, Ephrin B2, EphrinB2 |
| Simboli geni | EPHB1, EPHB2 |
| Vedi altri risultati |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?